Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cellular structures, including the cell wall, cytoplasmic membrane, and intracellular proteins, serve as the fundamental targets for antiseptic agents. In the context of clinical disinfection, the combination of chlorhexidine gluconate (CHG) and isopropyl alcohol (IPA) is frequently employed to achieve broad-spectrum antimicrobial activity. CHG is a cationic biguanide that adsorbs to the negatively charged microbial cell surface, leading to the disruption of the cytoplasmic membrane and subsequent leakage of vital intracellular components (StatPearls, 2023). Isopropyl alcohol acts as a rapid-acting agent that denatures proteins and solubilizes lipid bilayers, causing immediate cell lysis (CDC, 2008). This dual mechanism ensures both an immediate reduction in microbial load and a persistent antimicrobial effect on the skin surface. These structures are critical for the survival of pathogens such as Staphylococcus aureus and Escherichia coli, making them vital targets for preventing surgical site infections and catheter-related bloodstream infections (PubMed: PMID 20849206). The efficacy of targeting these structures is typically measured by the reduction in colony-forming units (CFU) on the treated surface.
Chlorhexidine gluconate disrupts the cell membrane and precipitates cytoplasm, while isopropyl alcohol denatures proteins and dissolves lipids.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cellular structures.